Inclusion Criteria : 
  -  Adults between age  18 and  75 
  -  Participants without a history of gastrointestinal disorders ( control group ) 
  -  Participants with functional dyspepsia ( FD group ) 
  -  Participants with moderate - to - severe irritable bowel syndrome ( defined by IBS symptom severity scores ( IBS - SSS ) greater than  250 ) ( IBS group ) 
Exclusion Criteria : 
  -  history of myocardial infarction , supplemental oxygen requirement , or diabetes
  -  history of chronic gastrointestinal symptoms ( for healthy control population only ) 
  -  history of gastric surgery
  -  psychosis or altered cognitive status
  -  history of head injury , metal in the skull , stroke , or a history of seizures
  -  implantable devices , such as a pacemaker or nerve stimulator
  -  current use of the following medications or use of substances which are known to lower the seizure threshold : amitriptyline ( Elavil )  , nortriptyline ( Pamelor )  , imipramine ( Tofranil )  , doxepin ( Sinequan )  , clozapine ( Clozaril )  , chlorpromazine ( Thorazine )  , amphetamines or methamphetamine , Ecstasy , Ketamine , Angel Dust / phencyclidine ( PCP )  , cocaine , or  3 or more alcoholic drinks per day
  -  pregnancy